![]() |
CiteULike | ![]() |
Group: Koch_Lab | ![]() |
![]() |
|
![]() |
Register | ![]() |
Log in | ![]() |
Histone H2B ubiquitination: the cancer connection — Genes & Development |
Reviews
[Write a review of this article]
Notes for this articlecommentary on an article in the same issue that I have not yet read. easy commentary to read, reviewing what was known mid-2008 about histone H2B-ubiquitylation and relation to up- and down-regulation of transcription. One of the human subunits of Bre1 (the E3 ligase), RNF20 appears to be a tumor supressor. While the corresponding de-ubiquitinase showed up as a strong oncogene in the paper He is talking about.
Find related articles from these CiteULike users
Find related articles with these CiteULike tags
Posting History
AbstractPost-translational modifications of histones play a critical role in gene expression control. Ultimately, cancer is a disease of aberrant gene expression. Accordingly, several histone-modifying enzymes have been described as proto-oncogenes or tumor suppressors. Recent reports, including one from Shema and colleagues (pp. 2664– 2676) in the October 1, 2008, issue of Genes and Development, indicate that deregulation of histone H2B monoubiquitination may contribute to cancer development.
BibTeX record
RIS record